I 
115TH CONGRESS 
1ST SESSION H. R. 3964 
To amend the Controlled Substances Act to establish additional registration 
requirements for prescribers of opioids, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 5, 2017 
Mr. ROE of Tennessee (for himself, Ms. KUSTER of New Hampshire, Mr. 
MACARTHUR, Mrs. RADEWAGEN, and Miss GONZA´LEZ-COLO´N of Puerto 
Rico) introduced the following bill; which was referred to the Committee 
on Energy and Commerce, and in addition to the Committee on the Judi-
ciary, for a period to be subsequently determined by the Speaker, in each 
case for consideration of such provisions as fall within the jurisdiction of 
the committee concerned 
A BILL 
To amend the Controlled Substances Act to establish addi-
tional registration requirements for prescribers of 
opioids, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Opioid Addiction Pre-
vention Act of 2017’’. 
VerDate Sep 11 2014 
01:51 Oct 07, 2017
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3964.IH
H3964
lotter on DSKBCFDHB2PROD with BILLS
SEC. 2. REGISTRATION REQUIREMENTS FOR PRESCRIBERS. 
Section 303 of the Controlled Substances Act (21 
U.S.C. 823) is amended by adding at the end the fol-
lowing: 
‘‘(k)(1) The Attorney General shall not register, or 
renew the registration of, a practitioner under subsection 
(f) who is licensed under State law to prescribe controlled 
substances in schedule II, III, or IV, unless the practi-
tioner submits to the Attorney General, for each such reg-
istration or renewal request, a certification that the practi-
tioner, during the applicable registration period, will not 
prescribe, for the initial treatment of acute pain, any 
schedule II, III, or IV opioid, other than an opioid pre-
scription described in paragraph (3)— 
‘‘(A) without firstly or concomitantly pre-
scribing one or more non-opioid analgesics, if there 
are no contraindications to such analgesics; 
‘‘(B) without clearly stating on the prescription 
the diagnosis for which the opioid is prescribed; 
‘‘(C) unless the prescribed opioid dose is the 
lowest effective dose; 
‘‘(D) an extended release or long acting formu-
lation of the opioid; and 
‘‘(E) in an amount in excess of the lesser of— 
‘‘(i) a 10-day supply (for which no refill is 
available); or 
VerDate Sep 11 2014 
01:51 Oct 07, 2017
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3964.IH
H3964
lotter on DSKBCFDHB2PROD with BILLS
‘‘(ii) an opioid prescription limit estab-
lished under State law. 
‘‘(2) In this subsection, the term ‘acute pain’— 
‘‘(A) means pain with abrupt onset and caused 
by a discrete injury, surgical procedure, or other ill-
ness of limited duration; and 
‘‘(B) does not include— 
‘‘(i) chronic pain; 
‘‘(ii) pain being treated as part of cancer 
care; 
‘‘(iii) hospice or other end-of-life care; or 
‘‘(iv) pain being treated as part of pallia-
tive care. 
‘‘(3) An opioid prescription described in this para-
graph is a prescription— 
‘‘(A) for a schedule II, III, or IV opioid drug 
approved by the Food and Drug Administration for 
an indication for the treatment of addiction; and 
‘‘(B) that is for the treatment of addiction.’’. 
Æ 
VerDate Sep 11 2014 
01:51 Oct 07, 2017
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H3964.IH
H3964
lotter on DSKBCFDHB2PROD with BILLS